MISSION Therapeutics Receives £20m Series B Funding

News   Dec 09, 2013

 
MISSION Therapeutics Receives £20m Series B Funding
 

RELATED ARTICLES

Drug Transport Gene May Explain Why Ovarian Cancer Patients React Differently to Chemotherapy

News

A gene which produces a protein that transports drugs in and out of cells may explain why some women treated with chemo have serious side effects.

READ MORE

Induced Pluripotent Stem Cells Could Serve as Cancer Vaccine

News

Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or disease. Now, a study in mice suggests another use for iPS cells: training the immune system to attack or even prevent tumors.

READ MORE

The Inflammatory Path to Pancreatic Cancer

News

Researchers have laid out a pathway of altered gene expression that links inflammation and pancreatic cancer.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE